Zdrowie i gospodarka · 01/08/2014

FDA Requests Public Comment on Proposed Collection of Information for Fast Track Drug Development Programs

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to fast track drug development programs, as outlined in the agency's Guidance for Industry on Fast Track Drug Development Programs: Designation, Development, and Application Review.